INTRODUCTION: We sought to explore the current state of evidence on sulfonylurea therapy in type 2 diabetes mellitus (T2DM) and critically examine the recommendations of major practice guidelines. and the overall ramifications of the issues thereof in current clinical practice. METHOD: We searched PUBMED. MEDLINE and other databases. https://www.alarecre.com/